Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Castanheira M, Mendes RE, Gales AC. Global epidemiology and mechanisms of resistance of Acinetobacter baumannii-calcoaceticus complex. Clin Infect Dis. 2023;76(Suppl 2):S166–78.
2. US Food and Drug Administration. FDA approves new treatment for pneumonia caused by certain difficult-to-treat bacteria [media release]. 23 May 2023. https://www.fda.gov.
3. US Centers for Disease Control and Prevention. Carbapenem-resistant Acinetobacter baumannii (CRAB): an urgent public health threat in United States healthcare facilities. 2021. https://arpsp.cdc.gov/. Accessed 12 June 2023.
4. World Health Organisation. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017. https://www.who.int/. Accessed 12 June 2023.
5. Shields RK, Paterson DL, Tamma PD. Navigating available treatment options for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex infections. Clin Infect Dis. 2023;76(Suppl 2):S179–93.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献